Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiujing He

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|January 2, 2023
Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?Peixin Du, Jing Jing, Xiujing He
Frontiers in Oncology|August 1, 2022
Single-Cell Metabolomics in Hematopoiesis and Hematological MalignanciesFengli Zuo, Jing Yu, Xiujing He
Frontiers in Pharmacology|December 13, 2021
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint ImmunotherapyXiujing He, Jing Yu, Hubing Shi
Journal of Clinical Medicine|January 21, 2023
Overview of Artificial Intelligence in Breast Cancer Medical ImagingDan Zheng, Xiujing He, Jing Jing
Journal of Clinical Medicine|February 25, 2023
Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer ImmunotherapyYu Gui, Xiujing He, Jing Yu, et al.
Frontiers in Pharmacology|August 8, 2022
Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical OutcomesDan Zheng, Xiaolin Hou, Jing Yu, et al.
Seminars in Cancer Biology|January 3, 2023
Artificial intelligence-based multi-omics analysis fuels cancer precision medicineXiujing He, Xiaowei Liu, Fengli Zuo, et al.
Frontiers in Pharmacology|July 18, 2019
Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian PopulationsJiqiao Yang, Xiujing He, Qing Lv, et al.
Frontiers in Immunology|November 17, 2022
The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancerYufei Xu, Fengli Zuo, Huiling Wang, et al.
Frontiers in Public Health|January 27, 2023
Application of artificial intelligence to the public health educationXueyan Wang, Xiujing He, Jiawei Wei, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|January 2, 2023
Microbiota and their metabolites potentiate cancer immunotherapy: Therapeutic target or resource for small molecule drug discovery?Peixin Du, Jing Jing, Xiujing He
Frontiers in Oncology|August 1, 2022
Single-Cell Metabolomics in Hematopoiesis and Hematological MalignanciesFengli Zuo, Jing Yu, Xiujing He
Frontiers in Pharmacology|December 13, 2021
Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint ImmunotherapyXiujing He, Jing Yu, Hubing Shi
Journal of Clinical Medicine|January 21, 2023
Overview of Artificial Intelligence in Breast Cancer Medical ImagingDan Zheng, Xiujing He, Jing Jing
Journal of Clinical Medicine|February 25, 2023
Artificial Intelligence-Assisted Transcriptomic Analysis to Advance Cancer ImmunotherapyYu Gui, Xiujing He, Jing Yu, et al.
Frontiers in Pharmacology|August 8, 2022
Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical OutcomesDan Zheng, Xiaolin Hou, Jing Yu, et al.
Seminars in Cancer Biology|January 3, 2023
Artificial intelligence-based multi-omics analysis fuels cancer precision medicineXiujing He, Xiaowei Liu, Fengli Zuo, et al.
Frontiers in Pharmacology|July 18, 2019
Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian PopulationsJiqiao Yang, Xiujing He, Qing Lv, et al.
Frontiers in Immunology|November 17, 2022
The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancerYufei Xu, Fengli Zuo, Huiling Wang, et al.
Frontiers in Public Health|January 27, 2023
Application of artificial intelligence to the public health educationXueyan Wang, Xiujing He, Jiawei Wei, et al.
Pageof 4